Immune-complex vasculitis: role of complement and IgG-Fc receptor functions.
暂无分享,去创建一个
[1] J. Unkeless. Function and heterogeneity of human Fc receptors for immunoglobulin G. , 1989, The Journal of clinical investigation.
[2] D. Fearon,et al. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis , 1988, The Journal of experimental medicine.
[3] N. Cooper,et al. CR2 ligands modulate human B cell activation. , 1988, Journal of immunology.
[4] J. Loike,et al. Complement receptor type three (CD11b/CD18) of human polymorphonuclear leukocytes recognizes fibrinogen. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[5] M. Berger,et al. Functional differences between the 40 kDa and 50 to 70 kDa IgG Fc receptors on human neutrophils revealed by elastase treatment and antireceptor antibodies. , 1988, Journal of immunology.
[6] R. Frade,et al. Monoclonal and anti-idiotypic anti-EBV/C3d receptor antibodies detect two binding sites, one for EBV and one for C3d on glycoprotein 140, the EBV/C3dR, expressed on human B lymphocytes. , 1988, Journal of immunology.
[7] F. Finkelman,et al. Ligand-loaded but not free complement receptors for C3b/C4b and C3d co-cap with cross-linked B cell surface IgM and IgD. , 1988, Journal of immunology.
[8] D. Fearon. Complement, C receptors, and immune complex disease. , 1988, Hospital practice.
[9] A. Fauci,et al. Response: The role of trimethoprim/sulfamethoxazole in the treatment of Wegener's granulomatosis , 1988 .
[10] R. Deremee. The treatment of Wegener's granulomatosis with trimethoprim/sulfamethoxazole: illusion or vision? , 1988, Arthritis and rheumatism.
[11] Clark,et al. Defect in the membrane expression of high affinity 72-kD Fc gamma receptors on phagocytic cells in four healthy subjects. , 1988, The Journal of clinical investigation.
[12] R. Winchester,et al. Up-regulation of the iC3b receptor (CR3) is neither necessary nor sufficient to promote neutrophil aggregation. , 1988, The Journal of clinical investigation.
[13] N. Hogg,et al. Neutrophil and monocyte cell surface p150,95 has iC3b-receptor (CR4) activity resembling CR3. , 1988, The Journal of clinical investigation.
[14] P. Schena,et al. Polymeric IgA and IgA rheumatoid factor decrease the capacity of serum to solubilize circulating immune complexes in patients with primary IgA nephropathy. , 1988, Journal of immunology.
[15] F. Arnett,et al. Molecular heterogeneity of complement component C4-null and 21-hydroxylase genes in systemic lupus erythematosus. , 1988, Arthritis and rheumatism.
[16] R. Deremee,et al. Cyclophosphamide-induced bladder toxicity in Wegener's granulomatosis. , 1988, Arthritis and rheumatism.
[17] W. Druml,et al. Cyclosporin in Wegener granulomatosis. , 1988, Annals of internal medicine.
[18] M. Walport,et al. The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor 1-dependent mechanisms. , 1988, Journal of immunology.
[19] G. Stewart,et al. Quinidine‐induced allergic granulomatous angiitis: an unusual cause of acute renal failure , 1988, The Medical journal of Australia.
[20] R. Bache,et al. Wegener's granulomatosis with acute pericardial tamponade. , 1988, Arthritis and rheumatism.
[21] J. Bonnetblanc,et al. Dapsone and rheumatoid vasculitis leg ulcerations. , 1988, Journal of the American Academy of Dermatology.
[22] B. Berggren,et al. Computed tomography of the brain in cases with venous vasculitis compared with an age-matched reference group. , 1988, Acta radiologica.
[23] G. Nemerow,et al. Immunobiology of CR2, the B lymphocyte receptor for Epstein-Barr virus and the C3d complement fragment. , 1988, Annual review of immunology.
[24] D. Houghton,et al. Inherited C3 deficiency with recurrent infections and glomerulonephritis. , 1988, American journal of diseases of children.
[25] P. Bacon. Vasculitis--clinical aspects and therapy. , 2009, Acta medica Scandinavica. Supplementum.
[26] C. Wilson. Immune aspects of renal diseases. , 1987, JAMA.
[27] J. Myers,et al. Wegener's granulomatosis presenting with massive pulmonary hemorrhage and capillaritis. , 1987, The American journal of surgical pathology.
[28] P. Klein,et al. Plasma Thrombospondin as an Indicator of Intravascular Platelet Activation in Patients with Vasculitis , 1987, Thrombosis and Haemostasis.
[29] B. R. Kaye,et al. Cerebral vasculitis associated with cocaine abuse. , 1987, JAMA.
[30] J. Axelson,et al. Wegener granulomatosis and trimethoprim-sulfamethoxazole. , 1987, Annals of internal medicine.
[31] W. Mccune,et al. Correlation of angiographic abnormalities with disease manifestations and disease severity in polyarteritis nodosa. , 1987, The Journal of rheumatology.
[32] S. Pillemer,et al. IgA related disorders in rheumatoid arthritis. , 1987, The Journal of rheumatology.
[33] L. Truedsson,et al. Clinical and serological features of severe vasculitis in rheumatoid arthritis: prognostic implications. , 1987, Annals of the rheumatic diseases.
[34] L. Guillevin,et al. Human immunodeficiency virus antibodies and systemic vasculitis. , 1987, Arthritis and rheumatism.
[35] B. Clotet,et al. Cutaneous vasculitis associated with propylthiouracil therapy. , 1987, Archives of internal medicine.
[36] E. H. Epstein,et al. Severe vasculitis during isotretinoin therapy. , 1987, Archives of dermatology.
[37] M. Walport,et al. Inherited deficiency of erythrocyte complement receptor type 1 does not cause susceptibility to systemic lupus erythematosus. , 1987, Arthritis and rheumatism.
[38] M. Grossman,et al. Recurrent Cutaneous Vascuiitis in Cystic Fibrosis , 1987 .
[39] A. Cats,et al. Diminished uptake and degradation of soluble aggregates of IgG by monocytes of patients with rheumatoid arthritis and vasculitis. , 1987, The Journal of rheumatology.
[40] K. Upchurch,et al. Low-dose methotrexate therapy for cutaneous vasculitis of rheumatoid arthritis. , 1987, Journal of the American Academy of Dermatology.
[41] W. Gross,et al. Autoantibodies against cytoplasmic structures of neutrophil granulocytes in Wegener's granulomatosis. , 1987, Clinical and experimental immunology.
[42] T. Hannedouche,et al. Penicillin-induced hypersensitivity vasculitides. , 1987, The Journal of antimicrobial chemotherapy.
[43] N. Scharff,et al. Reversible valvulitis in Wegener's granulomatosis. , 1987, Chest.
[44] M. Mannik. Mechanisms of tissue deposition of immune complexes. , 1987, The Journal of rheumatology. Supplement.
[45] J. Todd,et al. Wegener granulomatosis and trimethoprim-sulfamethoxazole. Complete remission after a twenty-year course. , 1987, Annals of internal medicine.
[46] L. Cerullo,et al. Phenylpropanolamine: an over-the-counter drug causing central nervous system vasculitis and intracerebral hemorrhage. Case report and review. , 1987, Neurosurgery.
[47] A. Woolf,et al. Factor VIII related antigen in the assessment of vasculitis. , 1987, Annals of the rheumatic diseases.
[48] J. G. Abuelo,et al. Severe Glomerulonephritis with Late Emergence of Classic Wegener's Granulomatosis: REPORT OF 4 CASES AND REVIEW OF THE LITERATURE , 1987, Medicine.
[49] G. Kammer,et al. Cerebral angiography as a guide for therapy in isolated central nervous system vasculitis. , 1987, JAMA.
[50] P. Schur,et al. Deficiency of the C3b/C4b receptor (CR1) of erythrocytes in systemic lupus erythematosus: analysis of the stability of the defect and of a restriction fragment length polymorphism of the CR1 gene. , 1987, Journal of immunology.
[51] J. Snedeker,et al. Cytomegalovirus infection in an infant presenting with cutaneous vasculitis. , 1987, The Pediatric infectious disease journal.
[52] V. Tron,et al. Allergic angiitis of Churg and Strauss syndrome. Response to pulse methylprednisolone. , 1987, Chest.
[53] F. Malkinson,et al. Sulfone therapy in the treatment of leukocytoclastic vasculitis. Report of three cases. , 1987, Journal of the American Academy of Dermatology.
[54] D. Fearon,et al. Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins , 1987, The Journal of experimental medicine.
[55] S. Pizzo,et al. Defective release of tissue plasminogen activator in systemic and cutaneous vasculitis. , 1987, The American journal of medicine.
[56] D. Blanchard,et al. Necrotising vasculitis associated with captopril therapy. , 1987, European heart journal.
[57] D. Scott,et al. Polyarteritis and the kidney. , 1987, The Quarterly journal of medicine.
[58] E. J. Hodges,et al. Refractory scleritis due to Wegener's granulomatosis. , 1987, The Western journal of medicine.
[59] Gilbert Gj. Churg-Strauss syndrome: determining adequacy of corticosteroid dosage by the eosinophil count. , 1987 .
[60] L. Rosenbaum,et al. Serum sickness-like illness and leukocytoclastic vasculitis following intracoronary arterial streptokinase. , 1987, American heart journal.
[61] V. Schuster,et al. Coexistent Wegener's granulomatosis and anti-glomerular basement membrane disease. , 1987, Human pathology.
[62] R. Hené,et al. Treatment of Wegener's granulomatosis with cyclosporin. , 1987, Annals of the rheumatic diseases.
[63] Lie Jt. The classification and diagnosis of vasculitis in large and medium-sized blood vessels. , 1987 .
[64] J. A. Oliver,et al. Systemic vasculitis resembling periarteritis nodosa in the lupus-like syndrome induced by hydralazine. , 1987, American journal of nephrology.
[65] M. Walport,et al. Deficiency of the effector mechanisms of the immune response and autoimmunity. , 1987, Ciba Foundation symposium.
[66] P. Bouche,et al. Peripheral neuropathy in systemic vasculitis , 1986, Neurology.
[67] J. Vergnon,et al. Granulomatose de Wegener: intérêt du lavage broncho-alvéolaire: trois observations , 1986 .
[68] D. M. Volk,et al. Cutaneous polyarteritis nodosa in a patient with ulcerative colitis. , 1986, Journal of pediatric gastroenterology and nutrition.
[69] M. Glassman,et al. Immune-complex glomerulonephritis in Crohn's disease. , 1986, Journal of pediatric gastroenterology and nutrition.
[70] M. Shingu,et al. Serum alkaline ribonuclease derived from vascular endothelial cells is raised in patients with rheumatoid vasculitis. , 1986, Annals of the rheumatic diseases.
[71] P. Bauret,et al. [Efficacy of adenine arabinoside (vidarabine) in the treatment of periarteritis nodosa associated with chronic active viral hepatitis B]. , 1986, Gastroenterologie clinique et biologique.
[72] J. Karsh,et al. Polyarteritis nodosa presenting as serous otitis media in a patient receiving hyposensitization therapy. , 1986, The Journal of rheumatology.
[73] J. Schifferli,et al. The role of complement and its receptor in the elimination of immune complexes. , 1986, The New England journal of medicine.
[74] A. Kharazmi,et al. Elastase from polymorphonuclear leucocytes: a regulatory enzyme in immune complex disease. , 1986, Clinical and experimental immunology.
[75] Y. Privat,et al. Vascularite nécrosante cutanéo-systémique survenue en cours de désensibilisation. , 1986 .
[76] I. Stamenkovic,et al. Granulomes extra-vasculaires et périvasculaires et vasculite nécrosante associés à l'antigénémie de l'hépatite B , 1986 .
[77] W. Placek. Circulating immune complexes in patients with psoriasis. , 1986, Acta Universitatis Carolinae. Medica.
[78] F. Cosio,et al. Differential binding of immunoglobulin A and immunoglobulin G1 immune complexes to primate erythrocytes in vivo. Immunoglobulin A immune complexes bind less well to erythrocytes and are preferentially deposited in glomeruli. , 1986, The Journal of clinical investigation.
[79] J. Mathews,et al. Defective reticuloendothelial system C3b mediated clearance in rheumatoid arthritis and vasculitis. , 1985, The Journal of rheumatology.
[80] T. H. The,et al. AUTOANTIBODIES AGAINST NEUTROPHILS AND MONOCYTES: TOOL FOR DIAGNOSIS AND MARKER OF DISEASE ACTIVITY IN WEGENER'S GRANULOMATOSIS , 1985, The Lancet.
[81] D. Birmingham,et al. Complement depletion accelerates the clearance of immune complexes from the circulation of primates. , 1984, The Journal of clinical investigation.
[82] J. Zabriskie,et al. Immunological studies of post-streptococcal sequelae. Evidence for presence of streptococcal antigens in circulating immune complexes. , 1984, The Journal of clinical investigation.
[83] P. Lambert,et al. Capacity to solubilize immune complexes in sera and synovial fluids from patients with rheumatoid arthritis. , 1983, Arthritis and rheumatism.
[84] D. Birmingham,et al. Primate erythrocyte-immune complex-clearing mechanism. , 1983, The Journal of clinical investigation.
[85] B. Haynes,et al. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. , 1983, Annals of internal medicine.
[86] J. Schifferli,et al. Complement-mediated solubilization in patients with systemic lupus erythematosus, nephritis or vasculitis. , 1981, Clinical and experimental immunology.
[87] V. Nussenzweig,et al. Requirements for the solubilization of immune aggregates by complement. The role of the classical pathway. , 1978, The Journal of clinical investigation.
[88] V. Nussenzweig,et al. Requirements for the solubilization of immune aggregates by complement: assembly of a factor B-dependent C3-convertase on the immune complexes , 1977, The Journal of experimental medicine.
[89] G. Miller,et al. A new complement function: solubilization of antigen-antibody aggregates. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[90] M. Mannik,et al. Saturation of the reticuloendothelial system with soluble immune complexes. , 1974, Journal of immunology.